Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Insider Sells 1,691 Shares of Stock

Key Points

• Liquidia Technologies insider Sarah Krepp sold 1,691 shares of the company's stock on October 13th for a total of approximately $39,586, reducing her position by 1.18%.
• The company reported a loss of $0.49 EPS for the last quarter, missing estimates, but saw a substantial revenue increase of 141.5% year-over-year, reaching $8.84 million.
• Analysts have shown optimism, with several raising their price objectives for Liquidia Technologies shares, resulting in a consensus target price of $32.38 and a current rating of "Moderate Buy."

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Sarah Krepp sold 1,691 shares of the firm's stock in a transaction on Monday, October 13th. The shares were sold at an average price of $23.41, for a total transaction of $39,586.31. Following the transaction, the insider directly owned 141,439 shares of the company's stock, valued at $3,311,086.99. The trade was a 1.18% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Liquidia Technologies Trading Up 1.7%

Shares of LQDA stock traded up $0.39 during trading hours on Wednesday, hitting $23.16. 1,994,182 shares of the company's stock traded hands, compared to its average volume of 1,944,347. The stock's 50 day simple moving average is $25.00 and its 200 day simple moving average is $18.47. The stock has a market cap of $1.99 billion, a PE ratio of -13.62 and a beta of 0.15. Liquidia Technologies, Inc. has a 12 month low of $9.71 and a 12 month high of $29.94. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million for the quarter, compared to the consensus estimate of $3.90 million. The firm's quarterly revenue was up 141.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. NewEdge Advisors LLC bought a new position in shares of Liquidia Technologies during the second quarter valued at about $25,000. Hurley Capital LLC purchased a new stake in Liquidia Technologies during the first quarter worth about $32,000. GAMMA Investing LLC increased its holdings in Liquidia Technologies by 65.6% during the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock worth $44,000 after buying an additional 1,173 shares during the last quarter. Quarry LP purchased a new stake in Liquidia Technologies during the first quarter worth about $79,000. Finally, Steward Partners Investment Advisory LLC increased its holdings in Liquidia Technologies by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock worth $77,000 after buying an additional 1,200 shares during the last quarter. 64.54% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on LQDA shares. Wells Fargo & Company increased their price objective on shares of Liquidia Technologies from $25.00 to $31.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 13th. Raymond James Financial increased their price objective on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a "strong-buy" rating in a research report on Wednesday, August 13th. Needham & Company LLC upped their price target on Liquidia Technologies from $32.00 to $36.00 and gave the stock a "buy" rating in a research note on Tuesday, August 12th. Jefferies Financial Group started coverage on shares of Liquidia Technologies in a research note on Friday, August 15th. They issued a "buy" rating and a $43.00 price objective on the stock. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $35.00 price target on shares of Liquidia Technologies in a research report on Monday, October 6th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $32.38.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.